Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor Recurrence (IBTR! 2.0) after Breast-Conserving Therapy for Korean Patients.

Jung SP, Hur SM, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kim MK, Kil WH, Choe JH, Kim JH, Kim JS, Nam SJ, Bae JW, Lee JE.

J Breast Cancer. 2013 Mar;16(1):97-103. doi: 10.4048/jbc.2013.16.1.97. Epub 2013 Mar 31. Erratum in: J Breast Cancer. 2017 Mar;20(1):117.

2.

Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy.

Sanghani M, Truong PT, Raad RA, Niemierko A, Lesperance M, Olivotto IA, Wazer DE, Taghian AG.

J Clin Oncol. 2010 Feb 10;28(5):718-22. doi: 10.1200/JCO.2009.22.6662. Epub 2010 Jan 4.

3.

Validation of the Web-Based IBTR! 2.0 Nomogram to Predict for Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy.

Kindts I, Laenen A, Peeters S, Janssen H, Depuydt T, Nevelsteen I, Van Limbergen E, Weltens C.

Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1477-84. doi: 10.1016/j.ijrobp.2016.03.036. Epub 2016 Apr 2.

PMID:
27315662
4.

Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast.

Wang F, Li H, Tan PH, Chua ET, Yeo RM, Lim FL, Kim SW, Tan DY, Wong FY.

Clin Oncol (R Coll Radiol). 2014 Nov;26(11):684-91. doi: 10.1016/j.clon.2014.08.004. Epub 2014 Sep 4.

PMID:
25194727
5.

Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram.

Sweldens C, Peeters S, van Limbergen E, Janssen H, Laenen A, Patil S, Van Zee KJ, Weltens C.

Cancer J. 2014 Jan-Feb;20(1):1-7. doi: 10.1097/PPO.0000000000000025.

PMID:
24445756
6.

Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.

Komoike Y, Akiyama F, Iino Y, Ikeda T, Tanaka-Akashi S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H.

Breast Cancer. 2005;12(2):104-11.

7.

Improving local control with breast-conserving therapy: a 27-year single-institution experience.

Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F.

Cancer. 2005 Jul 1;104(1):20-9.

8.
9.

Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.

Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KK.

J Clin Oncol. 2012 Feb 20;30(6):600-7. doi: 10.1200/JCO.2011.36.4976. Epub 2012 Jan 17. Erratum in: J Clin Oncol. 2012 Jul 1;30(19):2424.

10.

A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making.

Pleijhuis RG, Kwast AB, Jansen L, de Vries J, Lanting R, Bart J, Wiggers T, van Dam GM, Siesling S.

Breast. 2013 Oct;22(5):773-9. doi: 10.1016/j.breast.2013.01.010. Epub 2013 Feb 23.

11.

Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.

Ishitobi M, Ohsumi S, Inaji H, Ohno S, Shigematsu H, Akiyama F, Iwase T, Akashi-Tanaka S, Sato N, Takahashi K, Oura S.

Cancer. 2012 Sep 15;118(18):4385-93. doi: 10.1002/cncr.27377. Epub 2012 Jan 17.

12.

Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.

Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H.

Cancer. 2006 Jan 1;106(1):35-41.

13.

Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.

Kim HJ, Han W, Yi OV, Shin HC, Ahn SK, Koh BS, Moon HG, You JH, Son BH, Ahn SH, Noh DY.

Breast Cancer Res Treat. 2011 Nov;130(2):499-505. doi: 10.1007/s10549-011-1736-3. Epub 2011 Aug 19.

PMID:
21853352
14.

Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.

Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KK.

Cancer. 2003 Feb 15;97(4):926-33.

15.
16.

The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.

Thaker NG, Hoffman KE, Stauder MC, Shaitelman SF, Strom EA, Tereffe W, Smith BD, Perkins GH, Huo L, Munsell MF, Pusztai L, Buchholz TA, Woodward WA.

Springerplus. 2015 Jan 30;4:36. doi: 10.1186/s40064-015-0840-y. eCollection 2015.

17.

[Safety of breast-conserving treatment for triple-negative breast cancer].

Wang L, Ouyang T, Wang T, Xie Y, Fan Z, Fan T, Li J.

Zhonghua Wai Ke Za Zhi. 2015 Dec 1;53(12):947-52. Chinese.

PMID:
26850668
18.

Erratum: Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor Recurrence (IBTR! 2.0) after Breast-Conserving Therapy for Korean Patients.

Jung SP, Hur SM, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kim MK, Kil WH, Choe JH, Kim JH, Kim JS, Nam SJ, Bae JW, Lee JE.

J Breast Cancer. 2017 Mar;20(1):117. doi: 10.4048/jbc.2017.20.1.117. Epub 2017 Mar 24.

19.

Preoperative MRI of the breast and ipsilateral breast tumor recurrence: Long-term follow up.

Gervais MK, Maki E, Schiller DE, Crystal P, McCready DR.

J Surg Oncol. 2017 Mar;115(3):231-237. doi: 10.1002/jso.24520. Epub 2017 Jan 20.

PMID:
28105662
20.

Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.

Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1005-15.

PMID:
10421533

Supplemental Content

Support Center